Sfoglia per Corso Innovation in immuno-mediated and hematological disorders
Mostrati risultati da 1 a 13 di 13
Analysis of T cell response in bladder cancer patients treated with Bacillus of Calmette-Guérin (BCG)
2024
Characterization of non-driver mutations and identification of different outcomes and treatment strategies based on NGS results in myelofibrosis patients in different clinical stages
2023
Characterization of the role of CCRL2 in lung and intestine immune surveillance
2024
Donor specific anti-HLA antibodies in Hematopoietic Stem Cell Transplantation. A stepwise project to establish a better definition of their role and a desensitization strategy
2021
Effect of TRPV receptor agonists in chronic myeloid leukemia
2022
Immune profile of cancer patients to improve selection and efficacy of immunotherapeutic strategies
2022
Immunostimulatory activity and regulation of extracellular 2’3’-cGAMP in human multiple myeloma
2022
Long-term in vivo host immune modulation following CD19-CAR-T cell therapy in diffuse large B-cell lymphoma and B-lineage ALL patients
2023
Mucosal microenvironment and host immunity in HPV-driven carcinogenesis
2021
Non-invasive minimal residual disease (MRD) analysis in diffuse large B-cell lymphoma (DLBCL)
2023
“Play it again, SAMHD1”: the hard life of an antiviral restriction factor during the intrinsic immune response against human cytomegalovirus infection
2020
Role of Bone Marrow Stromal cells in the regulation of NKG2D and DNAM-1 ligand expression on Multiple Myeloma cells
2022
The role of Notch signaling and epidermal cytokines in the Hailey-Hailey disease pathogenesis and in the DNA damage response
2021
Mostrati risultati da 1 a 13 di 13
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile